Chris H. Lexis

Maastricht, LI, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) - design and rationale of the left ventricular unloading trial domain.

A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) - design and rationale of the left ventricular unloading trial domain.

Journal: American heart journal
Published: May 29, 2024

Deep embedded clustering generalisability and adaptation for integrating mixed datatypes: two critical care cohorts.

Deep embedded clustering generalisability and adaptation for integrating mixed datatypes: two critical care cohorts.

Journal: Scientific reports
Published: August 14, 2023

A Rare Cause of Cardiogenic Shock: A Case Report of Aortic Regurgitation due to Rupture of a Fibrous Strand Suspending a Tricuspid Aortic Valve.

A Rare Cause of Cardiogenic Shock: A Case Report of Aortic Regurgitation due to Rupture of a Fibrous Strand Suspending a Tricuspid Aortic Valve.

Journal: CASE (Philadelphia, Pa.)
Published: October 29, 2021

Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT.

Two-year follow-up of 4 months metformin treatment vs. placebo in ST-elevation myocardial infarction: data from the GIPS-III RCT.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: April 03, 2017

Predictors of left ventricular remodeling after ST-elevation myocardial infarction.

Predictors of left ventricular remodeling after ST-elevation myocardial infarction.

Journal: The international journal of cardiovascular imaging
Published: November 22, 2016

The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality.

The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality.

Journal: Clinical cardiology
Published: October 28, 2016

The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction.

The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction.

Journal: PloS one
Published: July 19, 2016

Chronic ischemic mitral regurgitation and papillary muscle infarction detected by late gadolinium-enhanced cardiac magnetic resonance imaging in patients with ST-segment elevation myocardial infarction.

Chronic ischemic mitral regurgitation and papillary muscle infarction detected by late gadolinium-enhanced cardiac magnetic resonance imaging in patients with ST-segment elevation myocardial infarction.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: April 03, 2016

Right Ventricular Function After Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the Glycometabolic Intervention as Adjunct to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction III Trial).

Right Ventricular Function After Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the Glycometabolic Intervention as Adjunct to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction III Trial).

Journal: The American journal of cardiology
Published: February 05, 2016

Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial.

Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial.

Journal: PloS one
Published: September 15, 2015

Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction.

Galectin-3 and sST2 in prediction of left ventricular ejection fraction after myocardial infarction.

Journal: Clinica chimica acta; international journal of clinical chemistry
Published: September 03, 2015

The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial.

The effect of metformin on cardiovascular risk profile in patients without diabetes presenting with acute myocardial infarction: data from the Glycometabolic Intervention as adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) trial.

Journal: BMJ open diabetes research & care
Published: February 09, 2015
Showing 1-12 of 22

Last Updated: 09/26/2026